DOI:
10.1055/s-00000045
Der Nuklearmediziner
LinksClose Window
References
Hofman MS, Lawrentschuk N, Francis RJ. et al.
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Lancet 2020;
395: 1208-1216
DOI: 10.1016/s0140-6736(20)30314-7.
We do not assume any responsibility for the contents of the web pages of other providers.